Genpact Ltd
XBER:35G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genpact Ltd
XBER:35G
|
BM |
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
US |
Multiples-Based Value
The Multiples-Based Value for
Genpact Ltd (35G) under the Base Case is 46.69 EUR.
Compared with the current market price of 32.26 EUR, the stock appears
Undervalued by 31% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.